89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ETNB 89Bio, Inc.

盘后交易 09-05 19:28:54 EDT

8.87

+0.26

+3.02%

盘后8.87

+0.000.00%

16:47 EDT

最高8.95	最低8.49	成交量192.70万
今开8.62	昨收8.61	日振幅5.34%
总市值13.15亿	流通市值9.20亿	总股本1.48亿
成交额1,690万	换手率1.86%	流通股本1.04亿
市净率2.52	ROE-86.86%	每股收益-3.41
52周最高11.84	52周最低4.16	市盈率-2.60
股息0.00	股息收益率0.00	ROA-49.10%

北京优虎网络科技有限公司

{"stockData":{"symbol":"ETNB","market":"US","secType":"STK","nameCN":"89Bio, Inc.","latestPrice":8.87,"timestamp":1757102400000,"preClose":8.61,"halted":0,"volume":1927023,"hourTrading":{"tag":"盘后","latestPrice":8.87,"preClose":8.87,"latestTime":"16:47 EDT","volume":707161,"amount":6272518.069999999,"timestamp":1757105244455},"delay":0,"floatShares":103725128,"shares":148308250,"eps":-3.413952,"marketStatus":"盘后交易","change":0.26,"latestTime":"09-05 19:28:52 EDT","open":8.62,"high":8.95,"low":8.49,"amount":16904882.494374003,"amplitude":0.053426,"askPrice":10.1,"askSize":24,"bidPrice":8.49,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-3.413952,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1757116800000},"marketStatusCode":4,"adr":0,"listingDate":1573448400000,"exchange":"NASDAQ","adjPreClose":8.61,"postHourTrading":{"tag":"盘后","latestPrice":8.87,"preClose":8.87,"latestTime":"16:47 EDT","volume":707161,"amount":6272518.069999999,"timestamp":1757105244455},"volumeRatio":1.154548,"impliedVol":0.9696,"impliedVolPercentile":0.792},"requestUrl":"/m/hq/s/ETNB","defaultTab":"news","newsList":[{"id":"2559676634","title":"89Bio, Inc.盘中异动 急速上涨5.02%报9.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559676634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559676634?lang=zh_cn&edition=full","pubTime":"2025-08-13 03:24","pubTimestamp":1755026683,"startTime":"0","endTime":"0","summary":"北京时间2025年08月13日03时24分，89Bio, Inc.股票出现异动，股价急速拉升5.02%。截至发稿，该股报9.21美元/股，成交量66.6124万股，换手率0.45%，振幅5.53%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508130324439743adb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508130324439743adb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ETNB"],"gpt_icon":0},{"id":"2558698346","title":"89Bio, Inc.盘中异动 快速跳水5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558698346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558698346?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:45","pubTimestamp":1754919936,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时45分，89Bio, Inc.股票出现异动，股价急速跳水5.84%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Entero Therapeutics Inc.、Equillium, Inc.、Puma Biotechnology Inc涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.较为活跃，换手率分别为2750.99%、261.91%、82.65%，振幅较大的相关个股有Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.，振幅分别为74.27%、69.75%、20.72%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081121453694dcc4dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081121453694dcc4dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ETNB"],"gpt_icon":0},{"id":"1172959417","title":"异动解读 | 89Bio股价盘中大跌5.65%，季度业绩不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1172959417","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172959417?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:44","pubTimestamp":1754660693,"startTime":"0","endTime":"0","summary":"生物制药公司89Bio, Inc.今日盘中股价大跌5.65%，引发投资者关注。这一显著跌幅主要源于公司最新发布的季度财报未能达到分析师预期。根据89Bio公布的财报，截至6月30日的季度调整后每股亏损为71美分，远低于分析师平均预期的49美分亏损。这一业绩表现明显低于市场预期，导致投资者信心受挫。值得注意的是，89Bio今年以来的股价表现仍相对强劲，截至上一季度累计上涨21.2%。这表明尽管短期面临挑战，市场对89Bio的长期发展仍持相对乐观态度。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ETNB"],"gpt_icon":0},{"id":"1170327667","title":"异动解读 | 89Bio盘中大跌5.65%，季度亏损超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1170327667","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170327667?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:39","pubTimestamp":1754660364,"startTime":"0","endTime":"0","summary":"生物制药公司89Bio, Inc.今日盘中大跌5.65%，投资者对公司最新公布的季度业绩表示失望。根据公司公告，89Bio截至6月30日的季度调整后每股亏损为0.71美元，大幅超过分析师平均预期的0.49美元亏损。这已经是公司连续第四个季度未能达到盈利预期。尽管89Bio的股价今日遭遇重挫，但值得注意的是，该公司股票今年以来仍上涨了21.2%。投资者将密切关注89Bio未来的业绩表现，以评估公司能否扭转局面，实现盈利预期。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ETNB"],"gpt_icon":0},{"id":"2557530832","title":"89Bio, Inc.盘中异动 股价大涨5.16%报10.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557530832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557530832?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:52","pubTimestamp":1754488331,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时52分，89Bio, Inc.股票出现波动，股价快速上涨5.16%。截至发稿，该股报10.19美元/股，成交量18.0454万股，换手率0.12%，振幅5.78%。89Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806215211a478e13f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806215211a478e13f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ETNB","BK4585"],"gpt_icon":0},{"id":"2556581793","title":"89Bio, Inc.盘中异动 大幅下跌5.05%报9.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556581793","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556581793?lang=zh_cn&edition=full","pubTime":"2025-08-01 23:31","pubTimestamp":1754062282,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日23时31分，89Bio, Inc.股票出现波动，股价快速下跌5.05%。截至发稿，该股报9.02美元/股，成交量23.4534万股，换手率0.16%，振幅4.00%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801233122972d3437&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801233122972d3437&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ETNB","BK4139"],"gpt_icon":0},{"id":"2548151148","title":"89Bio, Inc.盘中异动 早盘股价大涨5.40%报10.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548151148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548151148?lang=zh_cn&edition=full","pubTime":"2025-07-02 23:01","pubTimestamp":1751468495,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日23时01分，89Bio, Inc.股票出现异动，股价急速拉升5.40%。截至发稿，该股报10.26美元/股，成交量49.4276万股，换手率0.34%，振幅6.58%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070223013597976bf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070223013597976bf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ETNB"],"gpt_icon":0},{"id":"2544602548","title":"89Bio, Inc.盘中异动 下午盘急速跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544602548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544602548?lang=zh_cn&edition=full","pubTime":"2025-06-17 01:11","pubTimestamp":1750093896,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日01时11分，89Bio, Inc.股票出现波动，股价大幅跳水5.19%。截至发稿，该股报9.87美元/股，成交量74.148万股，换手率0.51%，振幅6.13%。89Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.64%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617011136a4ac88bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617011136a4ac88bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4585","BK4139"],"gpt_icon":0},{"id":"2543454974","title":"89Bio, Inc.盘中异动 急速下挫5.03%报9.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543454974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543454974?lang=zh_cn&edition=full","pubTime":"2025-06-13 01:41","pubTimestamp":1749750079,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日01时41分，89Bio, Inc.股票出现波动，股价大幅跳水5.03%。截至发稿，该股报9.54美元/股，成交量279.07万股，换手率1.91%，振幅4.47%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613014120a4a5a456&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613014120a4a5a456&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ETNB"],"gpt_icon":0},{"id":"2539264433","title":"89Bio, Inc.盘中异动 临近午盘快速上涨5.09%报9.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539264433","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539264433?lang=zh_cn&edition=full","pubTime":"2025-05-29 23:31","pubTimestamp":1748532702,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日23时31分，89Bio, Inc.股票出现波动，股价大幅拉升5.09%。截至发稿，该股报9.70美元/股，成交量32.3953万股，换手率0.22%，振幅6.12%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.37%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529233142a6f20e6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529233142a6f20e6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ETNB","BK4585"],"gpt_icon":0},{"id":"2537427926","title":"89Bio, Inc.盘中异动 快速拉升5.06%报8.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537427926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537427926?lang=zh_cn&edition=full","pubTime":"2025-05-21 01:11","pubTimestamp":1747761088,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日01时11分，89Bio, Inc.股票出现异动，股价快速拉升5.06%。截至发稿，该股报8.09美元/股，成交量49.0713万股，换手率0.34%，振幅6.36%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521011128a6e65108&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521011128a6e65108&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ETNB","BK4585"],"gpt_icon":0},{"id":"2535829036","title":"89Bio, Inc.盘中异动 大幅跳水5.06%报7.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535829036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535829036?lang=zh_cn&edition=full","pubTime":"2025-05-15 21:57","pubTimestamp":1747317450,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日21时57分，89Bio, Inc.股票出现异动，股价快速下挫5.06%。截至发稿，该股报7.79美元/股，成交量5.6241万股，换手率0.04%，振幅4.51%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515215730a6e0741f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515215730a6e0741f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4585","BK4139"],"gpt_icon":0},{"id":"2535707843","title":"89Bio, Inc.盘中异动 快速上涨5.13%报8.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535707843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535707843?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:36","pubTimestamp":1747229787,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时36分，89Bio, Inc.股票出现异动，股价急速拉升5.13%。截至发稿，该股报8.20美元/股，成交量10.2479万股，换手率0.07%，振幅3.85%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421362797598710&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421362797598710&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ETNB","BK4139"],"gpt_icon":0},{"id":"2534279157","title":"89Bio, Inc.盘中异动 早盘急速拉升5.45%报8.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534279157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534279157?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:30","pubTimestamp":1747056623,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时30分，89Bio, Inc.股票出现异动，股价大幅上涨5.45%。截至发稿，该股报8.12美元/股，成交量6979股，换手率0.00%，振幅0.00%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213024a47b75cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213024a47b75cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4139","BK4585"],"gpt_icon":0},{"id":"2532064526","title":"89Bio, Inc.盘中异动 下午盘急速上涨5.03%报7.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532064526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532064526?lang=zh_cn&edition=full","pubTime":"2025-05-01 02:21","pubTimestamp":1746037264,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日02时21分，89Bio, Inc.股票出现波动，股价大幅拉升5.03%。截至发稿，该股报7.93美元/股，成交量97.3468万股，换手率0.67%，振幅6.29%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.35%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501022105a6cf2814&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501022105a6cf2814&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4139","BK4585"],"gpt_icon":0},{"id":"2530223645","title":"89Bio, Inc.盘中异动 大幅上涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530223645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530223645?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:43","pubTimestamp":1745847816,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时43分，89Bio, Inc.股票出现波动，股价大幅拉升5.40%。截至发稿，该股报7.32美元/股，成交量9.4096万股，换手率0.06%，振幅4.90%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428214336a6cbc311&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428214336a6cbc311&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4585","BK4139"],"gpt_icon":0},{"id":"2527164173","title":"89Bio, Inc.盘中异动 大幅上涨5.97%报5.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527164173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527164173?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:30","pubTimestamp":1744637443,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时30分，89Bio, Inc.股票出现波动，股价快速上涨5.97%。截至发稿，该股报5.86美元/股，成交量3.6872万股，换手率0.03%，振幅0.00%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504142130449737831d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504142130449737831d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4585","BK4139"],"gpt_icon":0},{"id":"2518703262","title":"89Bio, Inc.盘中异动 股价大跌5.10%报7.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518703262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518703262?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:47","pubTimestamp":1741614433,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时47分，89Bio, Inc.股票出现波动，股价快速跳水5.10%。截至发稿，该股报7.45美元/股，成交量9.118万股，换手率0.06%，振幅3.95%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214713abf30247&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214713abf30247&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ETNB"],"gpt_icon":0},{"id":"2518440673","title":"89Bio, Inc.2024财年实现净利润-3.67亿美元，同比减少158.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518440673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518440673?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:00","pubTimestamp":1741449623,"startTime":"0","endTime":"0","summary":"3月9日，89Bio, Inc.公布财报，公告显示公司2024财年净利润为-3.67亿美元，同比减少158.45%；其中营业收入为0.00美元，每股基本收益为-3.51美元。从资产负债表来看，89Bio, Inc.总负债77.90百万美元，其中短期债务727000.00美元，资产负债比为0.07，流动比率为0.14。机构评级：截至2025年3月9日，当前有9家机构对89Bio, Inc.目标价做出预测，其中目标均价为29.67美元，其中最低目标价为12.00美元，最高目标价为51.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000038abef9700&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000038abef9700&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB"],"gpt_icon":0},{"id":"2516311371","title":"HC Wainwright & Co.：重申89bio(ETNB.US)评级，由买入调整至买入评级, 目标价由29.00美元调整至21.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516311371","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516311371?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:21","pubTimestamp":1740759694,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申89bio(ETNB.US)评级，由买入调整至买入评级, 目标价由29.00美元调整至21.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01002148469142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ETNB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.89bio.com","stockEarnings":[{"period":"1week","weight":-0.086},{"period":"1month","weight":-0.1115},{"period":"3month","weight":-0.16},{"period":"6month","weight":0.0968},{"period":"1year","weight":-0.0216},{"period":"ytd","weight":0.101}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":0.0337},{"period":"3month","weight":0.0834},{"period":"6month","weight":0.1271},{"period":"1year","weight":0.1782},{"period":"ytd","weight":0.1076}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"89bio, Inc.于2019年6月作为一家特拉华州公司成立，以经营2018年1月在以色列注册成立的89Bio有限公司的业务。该公司是一家临床阶段的生物制药公司，专注于治疗肝脏和心脏代谢疾病的创新疗法的开发和商业化。公司主导候选产品pegozafermin是一种专门设计的成纤维细胞生长因子的糖聚乙二醇化类似物，目前正在开发用于治疗非酒精性脂肪性肝炎和用于治疗严重的高甘油三酯血症。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.111427},{"month":2,"riseRate":0.666667,"avgChangeRate":0.102838},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.098837},{"month":4,"riseRate":0.5,"avgChangeRate":-0.083264},{"month":5,"riseRate":0.666667,"avgChangeRate":0.08296},{"month":6,"riseRate":0.5,"avgChangeRate":-0.019291},{"month":7,"riseRate":0.5,"avgChangeRate":0.06852},{"month":8,"riseRate":0.833333,"avgChangeRate":0.129221},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.057284},{"month":10,"riseRate":0.4,"avgChangeRate":-0.003798},{"month":11,"riseRate":0.6,"avgChangeRate":-0.000698},{"month":12,"riseRate":0.333333,"avgChangeRate":0.097135}],"exchange":"NASDAQ","name":"89Bio, Inc.","nameEN":"89Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供89Bio, Inc.(ETNB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"89Bio, Inc.,ETNB,89Bio, Inc.股票,89Bio, Inc.股票老虎,89Bio, Inc.股票老虎国际,89Bio, Inc.行情,89Bio, Inc.股票行情,89Bio, Inc.股价,89Bio, Inc.股市,89Bio, Inc.股票价格,89Bio, Inc.股票交易,89Bio, Inc.股票购买,89Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供89Bio, Inc.(ETNB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}